☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
proposed biosimilar
Samsung Bioepis Initiates P-III Clinical Trial of SB17 Proposed Biosimilar to Stelara (ustekinumab)
July 20, 2021
Bio-Thera Reports First Patient Dosing in P-III Study for BAT2206 Proposed Biosimilar of Stelara (ustekinumab)
July 16, 2021
Gan Lee Presents P-I Results of Proposed Biosimilar Insulins Aspart- Lispro and Glargine at ADA 2021
July 5, 2021
Alvotech Reaches PCD in its Switching Study for AVT02 (Proposed Biosimilar to Humira)
June 15, 2021
Alvotech Reports the US FDA and EMA's Acceptance of AVT02 Proposed Biosimilar to Humira (adalimumab)
November 20, 2020
Alvotech Reports Results of AVT02 (a proposed biosimilar to adalimumab) in Two Clinical Studies for Autoimmune Diseases
May 13, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.